Abstract
Purpose of Review
This review will provide recent pre-clinical and initial clinical trials exploring the efficacy of sonothrombolysis as an adjunct to current emergent therapies in acute coronary syndromes.
Recent Findings
The initial clinical trials examining the efficacy of short pulse duration diagnostic ultrasound (DUS) high mechanical index impulses in patients with ST segment elevation myocardial infarction (STEMI) have demonstrated that there is improved patency of the infarct vessel, and improved microvascular flow following percutaneous coronary intervention. Subsequent randomized prospective trials have confirmed that in patients with acute STEMI receiving an intravenous microbubble infusion, diagnostic high mechanical index impulses applied in the apical windows pre- and post-percutaneous coronary intervention have reduced myocardial infarction size, as assessed by magnetic resonance imaging at 72 h following presentation, and have been associated with better left ventricular systolic function at 6 month follow-up.
Summary
Sonothrombolysis has potential for improving early epicardial coronary artery patency and reduce left ventricular remodeling when added to current interventional strategies in STEMI.
Similar content being viewed by others
Abbreviations
- DUS:
-
Diagnostic ultrasound
- FDA:
-
Food and Drug Administration
- IC:
-
Inertial cavitation
- STEMI:
-
ST segment elevation myocardial infarction
- PWD:
-
Pulsed wave Doppler
- PCI:
-
Percutaneous coronary intervention
- MI:
-
Mechanical index
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Porter TR, Choudhury SA, Xie F. Utilization of diagnostic ultrasound and intravenous lipid-encapsulated perfluorocarbons in non-invasive targeted cardiovascular therapeutics. J Ther Ultrasound. 2016;4:18.
Porter TR, LeVeen RF, Fox R, Kricsfeld A, Xie F. Thrombolytic enhancement with perfluorocarbon-exposed sonicated dextrose albumin microbubbles. Am Heart J. 1996;132:964–8.
Tachibana K, Tachibana S. Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis. Circulation. 1995;92:1148–50.
Tsutsui JM, Xie F, Johanning J, Lof J, Cory B, He A, et al. Treatment of deeply located acute intravascular thrombi with therapeutic ultrasound guided by diagnostic ultrasound and intravenous microbubbles. J Ultrasound Med. 2006;25:1161–8.
Birnbaum Y, Luo H, Nagai T, Fishbein MC, Peterson TM, Li S, et al. Noninvasive in vivo clot dissolution without a thrombolytic drug: recanalization of thrombosed iliofemoral arteries by transcutaneous ultrasound combined with intravenous infusion of microbubbles. Circulation. 1998;97:130–4.
Nishioka T, Luo H, Fishbein MC, Cercek B, Forrester JS, Kim CJ, et al. Dissolution of thrombotic arterial occlusion by high intensity, low frequency ultrasound and dodecafluoropentane emulsion: an in vitro and in vivo study. J Am Coll Cardiol. 1997;30:561–8.
Xie F, Lof J, Everbach C, He A, Bennett RM, Matsunaga T, et al. Treatment of acute intravascular thrombi with diagnostic ultrasound and intravenous microbubbles. JACC Cardiovasc Imaging. 2009;2:511–8.
Vignon F, Shi WT, Powers JE, Everbach EC, Liu J, Gao S, et al. Microbubble cavitation imaging. IEEE Trans Ultrason Ferroelectr Freq Control. 2013;60:661–70.
•• Roos ST, Juffermans LJ, van Royen N, van Rossum AC, Xie F, Appelman Y, et al. Unexpected high incidence of coronary vasoconstriction in the reduction of microvascular injury using sonolysis (ROMIUS) trial. Ultrasound Med Biol. 2016;42:1919–28 This article demonstrated the initial clinical experience with diagnostic ultrasound impulses at a longer pulse duration (20 usec) in acute STEMI. It demonstrated the potential for early recanalization, but also vasoconstriction. This has not been observed with short pulse duration (<5 usec) high MI impulses.
•• Mathias W Jr, Tsutsui JM, Tavares BG, Xie F, Aguiar MO, Garcia DR, et al. Diagnostic ultrasound impulses improve microvascular flow in patients with STEMI receiving intravenous microbubbles. J Am Coll Cardiol. 2016;67:2506–15 This article presented pilot study findings which indicated diagnostic high MI impulses of short pulse duration, during a commercially available microbubble infusion, improve epicardial vessel patency and microvascular flow when added to emergent PCI in the treatment of acute STEMI.
Miller DL. Particle gathering and microstreaming near ultrasonically activated gas-filled micropores. J Acoust Soc Am. 1988;84:1378–87.
Chen X, Leeman JE, Wang J, Pacella JJ, Villanueva FS. New insights into mechanisms of sonothrombolysis using ultra-high-speed imaging. Ultrasound Med Biol. 2014;40:258–62.
Xie F, Gao S, Wu J, Lof J, Radio S, Vignon F, et al. Diagnostic ultrasound induced inertial cavitation to non-invasively restore coronary and microvascular flow in acute myocardial infarction. PLoS One. 2013;8:1–7.
Wu J, Xie F, Lof J, Sayyed S, Porter TR. Utilization of modified diagnostic ultrasound and microbubbles to reduce myocardial infarct size. Heart. 2015;101:1463–7.
Xie F, Lof J, Matsunaga T, Zutshi R, Porter TR. Diagnostic ultrasound combined with glycoprotein IIb/IIa – targeted microbubbles improves microvascular recovery after acute coronary thrombotic occlusions. Circulation. 2009;119:1378–85.
Xie F, Slikkerveer J, Gao S, Lof J, Kamp O, Unger E, et al. Coronary and microvascular thrombolysis with guided diagnostic ultrasound and microbubbles in acute ST segment elevation myocardial infarction. J Am Soc Echocardiogr. 2011;24:1400–8.
Gao S, Zhang Y, Wu J, Shi WT, Lof J, Vignon F, et al. Improvements in cerebral blood flow and recanalization rates with transcranial diagnostic ultrasound and intravenous microbubbles after acute cerebral emboli. Investig Radiol. 2014;49:593–600.
• Belcik JT, Mott BH, Xie A, Zhao Y, Kim S, Lindner NJ, et al. Augmentation of limb perfusion and reversal of tissue ischemia produced by ultrasound-mediated microbubble cavitation. Circ Cardiovasc Imaging. 2015;8:e002979 This article demonstrated the potential for diagnostic ultrasound induced inertial cavitation of microbubbles to improve skeletal muscle blood flow downstream from an acute iliac artery occlusion. This was shown to be mediated primarily by nitric oxide release. The increase in muscle blood flow was sustained for several minutes after the application of ultrasound.
Culp WC, Flores R, Brown AT, Lowery JD, Roberson PK, Hennings LJ, et al. Successful microbubble sonothrombolysis without tissue-type plasminogen activator in a rabbit model of acute ischemic stroke. Stroke. 2011;42:2280–5.
Porter TR, Xie F, Lof J, Powers J, Vignon F, Shi W, et al. The thrombolytic effect of diagnosis ultrasound induced microbubble cavitation in acute carotid thromboembolism. Investig Radiol. 2017;52:477–81.
Molina CA, Barreto AD, Tsivgoulis G, Sierzenski P, Malkoff MD, Rubiera M, et al. Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial. Ann Neurol. 2009;66:28–38.
Molina CA, Ribo M, Rubiera M, Montaner J, Santamarina E, Delgado-Mederos R, et al. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke. 2006;37:425–9.
Alexandrov AV, Mikulik R, Ribo M, Sharma VK, Lao AY, Tsivgoulis G, et al. A pilot randomized clinical safety study of sonothrombolysis augmentation with ultrasound-activated perflutren-lipid microspheres for acute ischemic stroke. Stroke. 2008;39:1464–9.
Slikkerveer J, Kleijn SA, Appleman Y, Porter TR, Veen G, van Rossum AC, et al. Ultrasound enhanced prehospital thrombolysis using microbubbles infusion in patients with acute ST elevation myocardial infarction: pilot of the sonolysis study. Ultrasound Med Biol. 2012;38:247–52.
•• Mathias W, Tsutsui JM, Tavares BG, Fava AM, Aguiar MOD, Borges BC, et al. Sonothrombolysis in st-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol. 2019;73:2832–42. This article is the first randomized study in humans which examines the effect of guided diagnostic high MI impulses and intravenously infused microbubbles to reduce myocardial infarct size and improve left ventricular systolic function at six month follow up.
•• Aggarwal S, Xie F, High R, Pavlides, Porter TR. Prevalence and predictive valve of microvascular flow abnormalities after successful contemporary percutaneous coronary intervention in acute st-segment elevation myocardial infarction. J Am Soc Echocardiogr. 2018:674–91 This article demonstrated the high prevalence of microvascular obstruction that is present, especially with left anterior descending thrombotic occlusions, after emergent percutaneous coronary interventions in STEMI.
Unger E, Porter T, Lindner J, Grayburn P. Cardiovascular drug delivery with ultrasound and microbubbles. Adv Drug Deliv Rev. 2014;72:110–26.
•• Choudhury SA, Xie F, Kutty S, Lof J, Stolze E, Porter TR. Selective infarct zone imaging with intravenous acoustically activated droplets. Plos One. 2018;13(12):e0207486 This article demonstrated the potential for intravenously administered nanometer-sized droplets, formed from commercially available microbubbles, to be activated by diagnostic ultrasound within the scar zone. The ability of droplets to penetrate a thrombus may improve the efficacy of sonothrombolysis.
Acknowledgments
The authors want to thank Megan Hoesing for her dedicated work in preparing this manuscript and to the Theodore Hubbard Foundation for funding of costs associated with manuscript preparation.
Author information
Authors and Affiliations
Contributions
TRP has written the entire paper, whereas WM has assisted with manuscript preparation and figures.
Corresponding author
Ethics declarations
Conflict of Interest
Dr. Porter receives research equipment support from Philips Ultrasound. From Bracco, Dr. Porter receives educational support and he is on their Speaker’s Bureau. Dr. Porter also receives salary and research support from the Theodore F. Hubbard Foundation. In addition, Dr. Porter has a patent issued on Thrombolytic Agents and Methods of Treatment for Thrombosis issued to #6,197,345).
Wilson Mathias Jr. declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Echocardiography
Rights and permissions
About this article
Cite this article
Porter, T.R., Mathias, W. Cardiovascular Sonothrombolysis. Curr Cardiol Rep 21, 86 (2019). https://doi.org/10.1007/s11886-019-1167-z
Published:
DOI: https://doi.org/10.1007/s11886-019-1167-z